MedTrace Logo

Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer

NCT01632956 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-02-06

No results posted yet for this study

Summary

There are few breast cancer support groups that focus on the specific needs of Chinese women. The purpose of this study is to learn about two different ways of providing support groups to help women of Chinese descent cope with the difficulties of a diagnosis of breast cancer and its treatment. The investigators want to learn about how best to support Chinese women with breast cancer by providing two different types of groups: an in-person support group and a virtual (online/phone) support group.

Conditions

  • Chinese Immigrants With Breast Cancer

Interventions

BEHAVIORAL

in-person support group

Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).

BEHAVIORAL

virtual support group

Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).

Sponsors & Collaborators

  • Cancer Support Community

    collaborator UNKNOWN

  • CHARLES B WANG COMMUNITY HEALTH CENTER

    collaborator UNKNOWN

  • Queens Health Network

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Jennifer Leng, MD, MPH · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01632956 on ClinicalTrials.gov